Literature DB >> 32438016

Use of virtual visits for the care of the arrhythmia patient.

Peter T Hu1, Henry Hilow1, Divyang Patel1, Megan Eppich1, Daniel Cantillon1, Patrick Tchou1, Mandeep Bhargava1, Mohamed Kanj1, Bryan Baranowski1, Ayman Hussein1, Thomas Callahan1, Walid Saliba1, Thomas Dresing1, Bruce L Wilkoff1, Peter A Rasmussen2, Oussama Wazni1, Khaldoun G Tarakji3.   

Abstract

BACKGROUND: Virtual visits (VVs) are a modality for delivering health care services remotely through videoconferencing tools. Data about patient and physician experience in using VVs are limited.
OBJECTIVE: The purpose of this study was to assess patient and physician experience with the use of VVs in cardiac electrophysiology.
METHODS: We performed a prospective survey of cardiac electrophysiology patients and physicians who participated in an outpatient VV from December 2018 to July 2019.
RESULTS: One-hundred consecutive VVs were included. Sixty-four patients elected to complete a survey. Patients rated their experience as either excellent/very good in scheduling a VV (87%), seeing their physician of choice (100%), transmitting arrhythmia data (88%), rating their physician's ability to communicate (98%), asking all questions (98%), rating the level of care received (98%), paying for the cost of a VV (67%), and rating their overall level of satisfaction (98%). Thirty-eight of 64 patients (59.4%) preferred a VV for their next visit, 12 of 64 (18.8%) preferred an in-office visit, 13 of 64 (20.3%) responded that their decision for a virtual or office visit depended on indication, and 1 of 64 (1.6%) had no preference. A total of 14 cardiac electrophysiologists participated in 100 VVs. Nine visits were not included due to technical difficulty. Physician responses to survey questions were rated as excellent/very good in the ability to communicate (92%), accessing monitoring data (95%), and overall level of satisfaction (98%).
CONCLUSION: In our small study population, most patients and physicians prefer VVs. Convenience, cost, and reason for follow-up were important determinants that affected both patient and physician preference.
Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiology; Digital health; Electrophysiology; Telehealth; Telemedicine; Virtual visits

Year:  2020        PMID: 32438016     DOI: 10.1016/j.hrthm.2020.05.011

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  5 in total

1.  Practical Utility of the Postal Service in Delivering a Self-Fitted, Wearable, Long-Term Electrocardiogram Monitoring Device for Outpatient Care.

Authors:  Mitsuru Takami; Koji Fukuzawa; Kunihiko Kiuchi; Makoto Takemoto; Toshihiro Nakamura; Jun Sakai; Atsusuke Yatomi; Kazutaka Nakasone; Yusuke Sonoda; Kyoko Yamamoto; Hiroyuki Takahara; Yuya Suzuki; Kenichi Tani; Ken-Ichi Hirata
Journal:  Circ Rep       Date:  2021-04-17

Review 2.  Deliver Cardiac Virtual Care: A Primer for Cardiovascular Professionals in Canada.

Authors:  Jeffrey Lam; Kamran Ahmad; Kenneth Gin; Chi-Ming Chow
Journal:  CJC Open       Date:  2021-10-09

3.  Atrial fibrillation future clinic. Novel platform to integrate smart device electrocardiogram into clinical practice.

Authors:  Cameron T Lambert; Divyang Patel; Joseph M Bumgarner; Mohamed Kanj; Daniel Cantillon; Walid Saliba; Ayman Hussein; Bryan Baranowski; Thomas Dresing; Mina K Chung; John Rickard; Niraj Varma; Thomas Callahan; David Martin; Patrick Tchou; Mandeep Bhargava; Kathy Wolski; Oussama Wazni; Khaldoun G Tarakji
Journal:  Cardiovasc Digit Health J       Date:  2021-03-04

4.  Changes in the digital health landscape in cardiac electrophysiology: A pre-and peri-pandemic COVID-19 era survey.

Authors:  Janet K Han; Sana M Al-Khatib; Christine M Albert
Journal:  Cardiovasc Digit Health J       Date:  2020-12-25

5.  Technology and cardiovascular diseases in the era of COVID-19.

Authors:  Amer Harky; Ahmed Adan; Malak Mohamed; Asha Elmi; Thomas Theologou
Journal:  J Card Surg       Date:  2020-10-10       Impact factor: 1.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.